Skip to content

Clinical Trial of Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia

Thoracoscopic Lobecotmy Under Spontaneous Ventilating Anesthesia or Intubated Anesthesia: A Prospective, Multicentre, Open-label, Randomized Control Trial

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03432637
Enrollment
450
Registered
2018-02-14
Start date
2018-03-05
Completion date
2024-03-31
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Keywords

Complications, Postoperative/Perioperative, video assisted thoracic surgery, non-intubated anaesthesia

Brief summary

With the development of video-assisted thoracoscopic surgery (VATS) techniques and technology for anesthesia control, non-intubated anesthesia with spontaneous ventilation has been widely applied in VATS. A prospective, multicentre, randomized controlled clinical study was applied in this study to assess the feasibility and safety of thoracoscopic lobectomy under spontaneous ventilation versus intubated single lung mechanical ventilation.

Detailed description

Intubated anesthesia with single lung mechanical ventilation (SLV) is considered the standard of care in VATS. However, this type of anesthesia has been associated with several adverse effects, which can trigger complications and increase the overall surgical risk. In order to avoid intubated-anesthesia related adverse effects, spontaneous ventilation strategies have been proposed in recent years.Encouraged by the satisfactory results with a preliminary experience of spontaneous ventilated VATS, the multicentre randomized controlled clinical controled study is established to comparatively analyze the outcome of patients undergoing either nonintubated intravenous anesthesia with spontaneous ventilation (SV) or SLV VATS lobectomy, especially in safety during operation, lymph nodes resection, complication rate, muscle recovery after surgery, the difference the postoperative hospitalization time.

Interventions

thoracoscopic lobectomy under spontaneous ventilation

PROCEDUREintubated anesthesia with single-lung mechanical ventilation

undergoing thoracoscopic lobectomy under intubated anesthesia with single-lung mechanical ventilation

Sponsors

Shenzhen People's Hospital
CollaboratorOTHER
Tongji Hospital
CollaboratorOTHER
Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* volunteering to participate in clinical trials and having the ability of responsibility can be signed informed consent. * 18-70 years old • preoperative chest CT diagnosed with localized lung bulla and needing surgical treatment * Eastern Cooperative Oncology Group(ECOG) score standard ≤ 1 • ASA(American Society of Anesthesiologists score) ≤ 2 * Heart ejection fraction( EF)≥ 50

Exclusion criteria

* refusing to participate in clinical trials • A history of tuberculosis or other diseases could cause pleural adhesion or more pleural effusion * BMI ≥ 25 kg/m\^2 * other not suitable situation

Design outcomes

Primary

MeasureTime frameDescription
numbers of participants with unstable vital signs, hypoxemia or hypercapnia intraoperativelyduring the surgical operation, an average of 1 hourthe numbers of participants with unstable vital signs or hypoxemia/hypercapnia will be reported. The vital signs will be monitored through the whole surgical operation(including heart rating in beat per minute, temperature in degree Celsius, respiratory in breaths per minute and blood pressure in oxygen in millimetres of mercury ), and blood gas analysis((including partial pressure of oxygen in millimetres of mercury, partial pressure of carbon dioxide in millimetres of mercury, and so on) will be tested every 30 mins during the operation.

Secondary

MeasureTime frameDescription
numbers of participants with postoperative complicationsfrom operation to discharging, an average of 1 weekThe numbers of participants with postoperative complications will be reported. The postoperative complications include postoperative respiratory complications(e.g., air leaks, lung infections, atelectasis, and bronchospasm and respiratory failure), postoperative cardiovascular complications(e.g., arrhythmias, myocardial infarction, cardiac failure) , intubated related complications(e.g., hoarseness, sore throat, and irritating cough), and other undefined complications
numbers of participants with anesthesia conversion intraoperatively in spontaneous ventilation groupduring the surgical operation, an average of 1 hourThe numbers of participants undergoing conversion from nonintubated spontaneous ventilation anaesthesia to intubated anaesthesia in nonintubated group will be reported because of hypoxemia, carbohemia, bleeding or other undefined reasons.

Other

MeasureTime frameDescription
the postoperative hospitalization time of every participantthrough the postoperative hospitalization time, an average of 1 weekthe postoperative time point of participants meeting the discharging criteria: body T°\<37.5℃, degree of blood oxygen saturation on room air\>95%, no complications requiring in-hospital treatment, full lung re-expansion after chest tube removal, and white blood cell count\<10×109/L

Countries

China

Contacts

Primary ContactFei Cui, Ph.D, M.D.
cuidavil@hotmail.com08618902301212

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026